Kang, N.; Liang, X.; Fan, B.; Zhao, C.; Shen, B.; Ji, X.; Liu, Y.
Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance. Cancers 2022, 14, 5681.
https://doi.org/10.3390/cancers14225681
AMA Style
Kang N, Liang X, Fan B, Zhao C, Shen B, Ji X, Liu Y.
Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance. Cancers. 2022; 14(22):5681.
https://doi.org/10.3390/cancers14225681
Chicago/Turabian Style
Kang, Nannan, Xue Liang, Buxi Fan, Chen Zhao, Beiyu Shen, Xuemei Ji, and Yu Liu.
2022. "Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance" Cancers 14, no. 22: 5681.
https://doi.org/10.3390/cancers14225681
APA Style
Kang, N., Liang, X., Fan, B., Zhao, C., Shen, B., Ji, X., & Liu, Y.
(2022). Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance. Cancers, 14(22), 5681.
https://doi.org/10.3390/cancers14225681